• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Characteristics and Predictors of Alzheimer's Disease Resilience Phenotype.阿尔茨海默病韧性表型的特征与预测因素
J Clin Med. 2023 Mar 23;12(7):2463. doi: 10.3390/jcm12072463.
2
Thal Amyloid Stages Do Not Significantly Impact the Correlation Between Neuropathological Change and Cognition in the Alzheimer Disease Continuum.地中海贫血淀粉样变阶段对阿尔茨海默病连续体中神经病理变化与认知之间的相关性没有显著影响。
J Neuropathol Exp Neurol. 2016 Jun;75(6):516-26. doi: 10.1093/jnen/nlw026. Epub 2016 Apr 22.
3
APOE ε4, Alzheimer's disease neuropathology and sleep disturbance, in individuals with and without dementia.载脂蛋白 E ε4、阿尔茨海默病神经病理学与睡眠障碍,在痴呆与非痴呆个体中。
Alzheimers Res Ther. 2022 Mar 30;14(1):47. doi: 10.1186/s13195-022-00992-y.
4
Cancer diagnosis is associated with a lower burden of dementia and less Alzheimer's-type neuropathology.癌症诊断与痴呆症负担降低和较少的阿尔茨海默病型神经病理学相关。
Brain. 2022 Jul 29;145(7):2518-2527. doi: 10.1093/brain/awac035.
5
Does taking statins affect the pathological burden in autopsy-confirmed Alzheimer's dementia?服用他汀类药物是否会影响尸检证实的阿尔茨海默病痴呆的病理负担?
Alzheimers Res Ther. 2018 Oct 2;10(1):104. doi: 10.1186/s13195-018-0430-7.
6
Cortical neuritic plaques and hippocampal neurofibrillary tangles are related to dementia severity in elderly schizophrenia patients.皮质神经突斑和海马神经纤维缠结与老年精神分裂症患者痴呆严重程度有关。
Schizophr Res. 2010 Jan;116(1):90-6. doi: 10.1016/j.schres.2009.10.013.
7
Apolipoprotein E allelotype is associated with neuropathological findings in Alzheimer's disease.载脂蛋白E等位基因型与阿尔茨海默病的神经病理学发现相关。
Virchows Arch. 2015 Aug;467(2):225-35. doi: 10.1007/s00428-015-1772-1. Epub 2015 Apr 22.
8
Neuropathological and genetic correlates of survival and dementia onset in synucleinopathies: a retrospective analysis.突触核蛋白病生存及痴呆症发病的神经病理学和遗传学关联:一项回顾性分析
Lancet Neurol. 2017 Jan;16(1):55-65. doi: 10.1016/S1474-4422(16)30291-5.
9
Resistance and resilience to tau pathology in Alzheimer's disease: Effects of age, sex, and alleles.阿尔茨海默病中对tau病理的抵抗和复原力:年龄、性别和等位基因的影响。
Alzheimers Dement (Amst). 2024 Oct 12;16(4):e70016. doi: 10.1002/dad2.70016. eCollection 2024 Oct-Dec.
10
The influence of Apolipoprotein E genotype on regional pathology in Alzheimer's disease.载脂蛋白 E 基因型对阿尔茨海默病区域性病理学的影响。
BMC Neurol. 2013 May 11;13:44. doi: 10.1186/1471-2377-13-44.

引用本文的文献

1
Resilience in Alzheimer's disease: Impact of operationalization and methodological choices.阿尔茨海默病中的复原力:操作化和方法选择的影响
Alzheimers Dement. 2025 Apr;21(4):e70185. doi: 10.1002/alz.70185.
2
Relationship between Cerebral Microinfarcts and Dementia by Sex: Findings from a community-based Autopsy Study.基于社区尸检研究的脑微梗死与痴呆症的性别关系:研究结果
Int J Cerebrovasc Dis Stroke. 2024;7(1). doi: 10.29011/2688-8734.100171. Epub 2024 Jan 17.
3
Quantitative estimate of cognitive resilience and its medical and genetic associations.认知弹性的定量评估及其与医学和遗传学的关联。
Alzheimers Res Ther. 2023 Nov 6;15(1):192. doi: 10.1186/s13195-023-01329-z.
4
Paradigm Shift: Multiple Potential Pathways to Neurodegenerative Dementia.范式转变:多种潜在的神经退行性痴呆途径。
Neurotherapeutics. 2023 Oct;20(6):1641-1652. doi: 10.1007/s13311-023-01441-w. Epub 2023 Sep 21.

本文引用的文献

1
High Soluble Amyloid-β42 Predicts Normal Cognition in Amyloid-Positive Individuals with Alzheimer's Disease-Causing Mutations.高可溶性淀粉样蛋白β42 可预测携带阿尔茨海默病致病突变的淀粉样蛋白阳性个体的正常认知。
J Alzheimers Dis. 2022;90(1):333-348. doi: 10.3233/JAD-220808.
2
APOE E2/E2 Is Associated with Slower Rate of Cognitive Decline with Age.载脂蛋白 E2/E2 与随年龄增长认知能力下降速度较慢有关。
J Alzheimers Dis. 2021;83(2):853-860. doi: 10.3233/JAD-201205.
3
The Relationship between Clinic Visit Accompanied by Family and Dementia Severity in Taiwan.台湾地区家庭陪同就诊与痴呆严重程度的关系。
Int J Environ Res Public Health. 2021 Feb 12;18(4):1792. doi: 10.3390/ijerph18041792.
4
is associated with longevity independent of Alzheimer's disease.与阿尔茨海默病无关,与长寿相关。
Elife. 2020 Oct 19;9:e62199. doi: 10.7554/eLife.62199.
5
Disease progression modeling of Alzheimer's disease according to education level.根据受教育程度对阿尔茨海默病的疾病进展进行建模。
Sci Rep. 2020 Oct 8;10(1):16808. doi: 10.1038/s41598-020-73911-6.
6
Association of APOE e2 genotype with Alzheimer's and non-Alzheimer's neurodegenerative pathologies.载脂蛋白 E e2 基因型与阿尔茨海默病和非阿尔茨海默病神经退行性病变的关联。
Nat Commun. 2020 Sep 18;11(1):4727. doi: 10.1038/s41467-020-18198-x.
7
Resistance and resilience to Alzheimer's disease pathology are associated with reduced cortical pTau and absence of limbic-predominant age-related TDP-43 encephalopathy in a community-based cohort.在一个基于社区的队列中,阿尔茨海默病病理的抗性和弹性与皮质 pTau 减少以及缺乏以边缘为主的与年龄相关的 TDP-43 脑炎有关。
Acta Neuropathol Commun. 2019 Jun 7;7(1):91. doi: 10.1186/s40478-019-0743-1.
8
Vascular Dysfunction in Alzheimer's Disease: A Prelude to the Pathological Process or a Consequence of It?阿尔茨海默病中的血管功能障碍:病理过程的前奏还是其结果?
J Clin Med. 2019 May 10;8(5):651. doi: 10.3390/jcm8050651.
9
Cognitive Resilience to Alzheimer's Disease Pathology in the Human Brain.人类大脑对阿尔茨海默病病理的认知弹性。
J Alzheimers Dis. 2019;68(3):1071-1083. doi: 10.3233/JAD-180942.
10
Tau pathology and neurodegeneration contribute to cognitive impairment in Alzheimer's disease.tau蛋白病变和神经退行性变导致阿尔茨海默病的认知障碍。
Brain. 2017 Dec 1;140(12):3286-3300. doi: 10.1093/brain/awx243.

阿尔茨海默病韧性表型的特征与预测因素

Characteristics and Predictors of Alzheimer's Disease Resilience Phenotype.

作者信息

Sin Mo-Kyung, Cheng Yan, Roseman Jeffrey M, Latimer Caitlin, Ahmed Ali, Zamrini Edward

机构信息

College of Nursing, Seattle University, Seattle, WA 98122-1090, USA.

The School of Medicine & Health Sciences, George Washington University, Washington, DC 20037, USA.

出版信息

J Clin Med. 2023 Mar 23;12(7):2463. doi: 10.3390/jcm12072463.

DOI:10.3390/jcm12072463
PMID:37048547
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10094896/
Abstract

Alzheimer's disease (AD) is characterized by cognitive impairment in the presence of cerebral amyloid plaques and neurofibrillary tangles. Less is known about the characteristics and predictors of resilience to cognitive impairment in the presence of neuropathological evidence of AD, the focus of this study. Of 3170 adults age ≥65 years in the National Alzheimer's Coordinating Center (NACC) brain autopsy cohort, 1373 had evidence of CERAD level moderate to frequent neuritic plaque density and Braak stage V-VI neurofibrillary tangles. Resilience was defined by CDR-SOB and CDR-Global scores of 0-2.5 and 0-0.5, respectively, and non-resilience, CDR-SOB and CDR-Global scores >2.5 and >0.5, respectively. Multivariable logistic regression models were used to examine the independent associations of patient characteristics with resilience. There were 62 participants (4.8%) with resilience. Those with resilience were older (mean age, 88.3 vs. 82.4 years), more likely to be women (61.3% vs. 47.3%) and had a lower prevalence of the APOE-e4 carrier (41.9% vs. 56.2%). They also had a higher prevalence of hypertension, heart failure, atrial fibrillation, diuretic use, beta-blocker use, and APOE-e2 carrier status. Greater age at death, diuretic use, and APOE-e2 were the only characteristics independently associated with higher odds of the AD resilience phenotype (adjusted OR, 1.09; 95% CI, 1.05-1.13; < 0.01; 2.00 (1.04-3.87), = 0.04, 2.71 (1.31-5.64), < 0.01, respectively). The phenotype of resilience to cognitive impairment is uncommon in older adults who have neuropathological evidence of AD.

摘要

阿尔茨海默病(AD)的特征是在存在脑淀粉样斑块和神经原纤维缠结的情况下出现认知障碍。对于在存在AD神经病理学证据的情况下对认知障碍具有恢复力的特征和预测因素知之甚少,本研究聚焦于此。在国家阿尔茨海默病协调中心(NACC)脑尸检队列的3170名年龄≥65岁的成年人中,1373人有CERAD水平为中度至频繁神经炎性斑块密度和Braak分期V-VI神经原纤维缠结的证据。恢复力分别由CDR-SOB和CDR-Global评分为0-2.5和0-0.5定义,而非恢复力则分别由CDR-SOB和CDR-Global评分>2.5和>0.5定义。使用多变量逻辑回归模型来检验患者特征与恢复力的独立关联。有62名参与者(4.8%)具有恢复力。具有恢复力的人年龄更大(平均年龄,88.3岁对82.4岁),更可能是女性(61.3%对47.3%),且APOE-e4携带者的患病率较低(41.9%对56.2%)。他们还具有更高的高血压、心力衰竭、心房颤动、使用利尿剂、使用β受体阻滞剂和APOE-e2携带者状态的患病率。更高的死亡年龄、使用利尿剂和APOE-e2是与AD恢复力表型较高几率独立相关的仅有的特征(调整后的OR,1.09;95%CI,1.05-1.13;P<0.01;2.00(1.04-3.87),P=0.04,2.71(1.31-5.64),P<0.01,分别)。在有AD神经病理学证据的老年人中,对认知障碍具有恢复力的表型并不常见。